. . . . . . . . . "portrazza tm is an epidermal growth factor receptor egfr antagonist indicated in combination with gemcitabine and cisplatin for first line treatment of patients with metastatic squamous non small cell lung cancer 1 1 limitation of use portrazza is not indicated for treatment of non squamous non small cell lung cancer 1 2 5 6 14 2 portrazza tm is indicated in combination with gemcitabine and cisplatin for first line treatment of patients with metastatic squamous non small cell lung cancer portrazza is not indicated for treatment of non squamous non small cell lung cancer see warnings and precautions 5 6 14 2" . . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "JQ3ur+2NrejCz4bLGmSGWxqqKT0y5vUUFvLIRmq8+kKGN7G67AG1JFNBzi8Tk4DpVcQJ4VbuaxY4dZR75Ir8I9HqKTSGB831XYcrRNuuwD17SVa/DXVYx3zp+A4CF449OpkxLiusyIRz3VMy2HB7dH6dVZDo86mkWsNbE1qhBNc=" . . "2021-06-12T12:49:14.696+02:00"^^ . . . . .